REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vasa Therapeutics Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Vasa Therapeutics Sp. z o.o. Profile Updated: October 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Vasa Therapeutics Sp. z o.o. is an enterprise in Poland, with the main office in Wroclaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on October 16, 2019. In 2023, the company reported a net sales revenue increase of 2.95%. Its’ total assets recorded a growth of 253.94%. In, 2023, the company’s net profit margin increased by 387.08%.

Headquarters
Ul. Dunska 9/D009
Wroclaw; Dolnoslaskie; Postal Code: 54-427

Contact Details: Purchase the Vasa Therapeutics Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vasa Therapeutics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Vasa Therapeutics Sp. z o.o. report to view the information.
Incorporation Date:
October 16, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
85.25%
Purchase this report to view the information.
14.75%
Company Performance
Financial values in the chart are available after Vasa Therapeutics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
2.95%▲
Total operating revenue
-80.1%▼
Operating profit (EBIT)
74.33%▲
Net Profit (Loss) for the Period
85.31%▲
Total assets
253.94%▲
Total equity
N/A
Operating Profit Margin (ROS)
315.54%▲
Net Profit Margin
387.08%▲
Return on Equity (ROE)
N/A
Quick Ratio
-0.76%▼
Cash Ratio
-0.84%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Sensitrial Polska Sp. z o.o.
 
Stem Cells Spin S.A.
Valueadd Pharma (By Dr. Murpani) sp. k.
 
Bioactive-Tech Sp. z o.o.
Verdant Nature Llc Oddzial W Polsce
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo